ABOUT INVESTMENT APPROACH PORTFOLIO TEAM NEWS CONTACT NEWS All News Argentum News Portfolio News News by company ANI Pharmaceuticals (6) November 4, 2021 EmpowerMX Awarded Major Multi-Year SaaS Contract from MRO Holdings October 12, 2021 Argentum Leads Strategic Investment in Lender Price to Support Rapid Growth October 5, 2021 Argentum Named Again in Inc.’s 2021 List of Founder-Friendly Investors September 21, 2021 Argentum Announces Promotion and New Team Member August 31, 2021 NuORDER, an Argentum Portfolio Company, is Acquired by Lightspeed for $425M August 19, 2021 LAUNCH Technical Workforce Solutions, LLC announced today they have formed a strategic partnership with Aviation Institute of Maintenance (AIM). May 19, 2021 Argentum Announces Two Promotions in Connection with its New Fund May 5, 2021 Argentum Supports Fleetworthy's Acquisition of Our Safety Department April 29, 2021 Argentum invests in UFA, a leading provider of mission-critical air traffic control (ATC) simulation and training software solutions April 20, 2021 Argentum Leads $13M Investment in SmartCommerce to Accelerate Growth and Extend Technology Platform March 11, 2021 Leading B2B commerce platform’s latest investment round signals fast-changing wholesale and retail landscape February 23, 2021 The ODP Corporation Accelerates Digital Transformation with the Acquisition of BuyerQuest Holdings, Inc February 23, 2021 Argentum Leads $11M Investment in Impact Analytics, a leading provider of AI-driven SaaS solutions for the retail industry January 25, 2021 EmpowerMX Appoints Aviation MRO Industry Veteran, Phil Bathurst, as Chief Commercial Officer October 27, 2020 Argentum Named a Top 50 Founder-Friendly Private Equity Firm by Inc. July 27, 2020 Mediant Announces $18.5 Million Equity Infusion to Support Next Phase of Growth September 21, 2015 ANI Pharmaceuticals, Inc. today announced that it has agreed to acquire the NDAs for purified corticotropin gel and corticotropin zinc hydroxide December 5, 2014 ANI Pharmaceuticals, Inc. today announced the pricing of an underwritten public offering of $125,000,000 aggregate principal amount of its 3.00% Convertible Senior Notes due 2019 March 10, 2014 ANI Pharmaceuticals, Inc. today announced the closing of its previously announced underwritten public offering of 1,612,903 shares of common stock December 26, 2013 ANI Pharmaceuticals, Inc. today announced that it has acquired 31 previously marketed generic drug products from Teva Pharmaceuticals for $12.5 million June 20, 2013 BioSante Pharmaceuticals, Inc. announced today that it has completed the merger of its wholly-owned subsidiary with and into ANI Pharmaceuticals, Inc. October 4, 2012 BioSante Pharmaceuticals, Inc. and ANI Pharmaceuticals, Inc. announced today that they have entered into a definitive merger agreement MORE Summary Overview DOWNLOAD PDF CONNECT FIND US 60 Madison Avenue Suite 701 New York, NY 10010 TALK TO US Phone: 212.949.6262 Fax: 212.949.8294 tag@argentumgroup.com JOIN OUR MAILING LIST This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. TERMS & PRIVACY SITEMAP © 2021 Argentum Group. All Rights Reserved. Website Design by MVP Marketing + Design